Stimcell Energetics (STME) Net Cash Flow Growth (5y) (2016 - 2026)
Stimcell Energetics (STME) Net Cash Flow Growth (5y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Stimcell Energetics | 4.65 Mn | 4.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -88.31% |
| Nov 30, 2025 | 19.22% |
| Aug 31, 2025 | -16.08% |
| May 31, 2025 | 16.14% |
| Feb 28, 2025 | 30.05% |
| Nov 30, 2024 | 16.79% |
| Aug 31, 2024 | -15.75% |
| May 31, 2024 | 12.03% |
| Feb 29, 2024 | -11.97% |
| Nov 30, 2023 | -54.42% |
| Aug 31, 2023 | -57.17% |
| May 31, 2023 | 51.40% |
| Feb 28, 2023 | 33.94% |
| Nov 30, 2022 | 15.33% |
| Aug 31, 2022 | -15.52% |
| May 31, 2022 | -16.09% |
| Feb 28, 2022 | 42.79% |
| Nov 30, 2021 | -18.38% |
| Aug 31, 2021 | 32.30% |
| May 31, 2021 | -18.90% |